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Objectives:Historically, women have higher procedurally related mortality rates than men for abdominal aortic aneurysm
(AAA) repair. Although endovascular aneurysm repair (EVAR) has improved these rates for men and women, effects of
gender on long-term survival with different types of AAA repair, such as EVAR vs open aneurysm repair (OAR), need
further investigation. To address this issue, we analyzed survival inmatched cohorts who received EVAR orOAR for both
elective (eAAA) and ruptured AAA (rAAA).
Methods: Using the Medicare Beneficiary Database (1995-2006), we compiled a cohort of patients who underwent OAR
or EVAR for eAAA (n  322,892) or rAAA (n  48,865). Men and women were matched by propensity scores,
accounting for baseline demographics, comorbid conditions, treating institution, and surgeon experience. Frailty models
were used to compare long-term survival of the matched groups.
Results: Perioperative mortality for eAAAs was significantly lower among EVAR vs OAR recipients for both men (1.84%
vs 4.80%) and women (3.19% vs 6.37%, P < .0001). One difference, however, was that the survival benefit of EVAR was
sustained for the 6 years of follow-up in women but disappeared in 2 years in men. Similarly, the survival benefit of men
vs women after elective EVAR disappeared after 1.5 to 2 years. For rAAAs, 30-day mortality was significantly lower for
EVAR recipients compared with OAR recipients, for both men (33.43% vs 43.70% P < .0001) and women (41.01% vs
48.28%, P  .0201). Six-year survival was significantly higher for men who received EVAR vs those who received OAR
(P .001). However, the survival benefit for women who received EVAR compared with OAR disappeared in 6 months.
Survival was also substantially higher for men than women after emergent EVAR (P  .0007).
Conclusions:Gender disparity is evident from long-termoutcomes afterAAA repair. In the case for rAAA,where the long-term
outcome for women was significantly worse than for men, the less invasive EVAR treatment did not appear to benefit women
to the same extent that it did for men. Although the long-term outcome after open repair for elective AAA was also worse for
women, EVAR benefit for women was sustained longer than for men. These associations require further study to isolate
specific risk factors that would be potential targets for improving AAA management. (J Vasc Surg 2011;54:1-12.)
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0Elective or urgent endovascular repair (EVAR) of
abdominal aortic aneurysms (AAA) has been widely ac-
cepted as the treatment of choice for these lesions.1 The
Dutch Randomised Endovascular Aneurysm Management
(DREAM), Comparison of Endovascular Aneurysm Repair
with Open Repair in Patients with Abdominal Aortic An-
eurysm (EVAR1), and Veterans Affairs Open versus Endo-
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C
dascular Repair (OVER) clinical trials,2,3 as well as
opulation-based observational studies,4,5 have demon-
trated improved 30-day mortality and morbidity with
VAR compared with open aneurysm repair (OAR). How-
ver, they failed to show sustained survival benefit after 2 to
years from the initial surgery.2-4
Historically, the natural history, as well as the manage-
ent of AAA in women has been associated with worse
verall outcomes.6-11 EVAR has improved immediate out-
omes in women compared with OAR; however, a gender
isparity in mortality persists.6,9,12,13 Whether this initial
enefit is sustained in long-term follow-up for women and
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July 20112 Egorova et alwhether the initial survival advantage associated with male
gender after EVAR or OAR persists over time needs further
investigation. This study addressed these issues from a
population perspective and determined the effect of gender
on long-term survival differences after OAR and EVAR
under elective and urgent circumstances.
METHODS
Data sources and population selection. The data
source for analysis was the Medicare Inpatient Standard
Analytical and Denominator files for years 1995-2006.
Patients were selected through a combination of diagnoses
codes (International Classification of Disease, 9th Clinical
Modification [ICD-9-CM] codes 441.4—AAA, without
mention of rupture, or 441.3—ruptured AAA) and ICD-9
procedure codes (39.71 for EVAR and 38.44, 39.25,
39.52, 38.34, 38.64, 38.40, 38.60 forOAR) in the primary
or any secondary position. The study excluded patients
with thoracic or thoracoabdominal aneurysms.
The hospitalization with the first AAA procedure was
Table I. Demographics and comorbidities for patients wh
repair of abdominal aortic aneurysm
Variable
Overall
Men Women
(n  250,438) (n  72,454)
Age, years 74.97 75.86
Age groups, %
65-69 22.8 18.5
70-74 29.8 28.1
75-79 27.1 28.7
80-84 15.1 17.6
85 5.2 7.1
Race, %
White 95.2 92.1
Black 2.4 5.4
Hispanic 0.6 0.5
Other 1.9 2.0
Comorbidities, %
Coronary 51.3 38.9
Valvular 8.7 9.9
Arrhythmia 27.8 22.5
CHF 15.8 17.6
Pulmonary 36.3 41.6
Cerebrovascular 7.6 8.2
Neurologic 4.2 4.0
Renal failure 4.8 4.5
PAD 20.6 27.9
Diabetes 12.8 11.0
Liver disease 1.2 1.2
Cancer 7.4 4.1
Hypertension 63.4 70.1
Hyperlipidemia 28.0 27.6
Procedure, %
EVAR 25.4 18.8
Conversion
OAR 74.6 81.2
CHF, Congestive heart failure; PAD, peripheral arterial disease.
aReflecting the introduction of the EVAR International Classification of Dis
during the last 6 years of the data set.identified as the index hospitalization. Preindex and index sospitalizations were used to assess baseline comorbidities.
he comorbidities included all those identified in prior
ospitalizations and the chronic conditions reported at the
ndex hospitalization. The comorbidities that were ana-
yzed are reported in Appendix Table O1 (online only).
The following perioperative outcomes were reviewed:
ardiac, respiratory, and acute renal failure requiring dialy-
is, patient disposition, and 30-day mortality. Long-term
dverse events included ruptured AAA, reoperation of
AA, arterial reinterventions (thrombectomy, embolec-
omy, catheter-based, and open reconstructive reinterven-
ions for readmissions with a primary or secondary diagnosis
f AAA) and interventions for incision- and laparotomy-
elated complications, including intestinal postoperative
bstruction, postoperative adhesions and incisional, groin
r abdominal wall hernia repairs (Appendix Table O1,
nline only).
Readmission rates were calculated per 1 year of survival.
discharge and readmission that occurred on the same day
as considered one episode of care. Annual hospital and
derwent elective endovascular (EVAR) or open (OAR)
EVARa
P
Men Women
P(n  63,712) (n  13,644)
.0001 76.16 77.45 .0001
.0001 18.9 13.8 .0001
.0001 25.7 23.0 .0001
.0001 27.5 28.2 .0928
.0001 19.4 22.5 .0001
.0001 8.5 12.5 .0001
.0001 95.2 90.8 .0001
.0001 2.4 6.6 .0001
.541 0.6 0.6 .4167
.0001 1.9 2.0 .223
.0001 57.0 42.3 .0001
.0001 9.3 10.7 .0001
.0001 26.6 20.6 .0001
.0001 15.0 16.1 .0017
.0001 35.9 41.8 .0001
.0001 7.3 6.8 .0518
.01 4.9 5.0 .6815
.0002 6.3 6.1 .3921
.0001 21.6 27.9 .0001
.0001 16.9 14.9 .0001
.3769 1.1 1.1 .8037
.0001 8.2 4.8 .0001
.0001 72.6 78.2 .0001
.0385 42.5 41.3 .009
.0001 100.0 100.0
2.0 4.6 .0001
.0001
th edition, procedure code in 2000, EVAR procedures were only identifiedo un
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Volume 54, Number 1 Egorova et al 3of EVAR, OAR, or ruptured AAA (rAAA) repairs (EVAR
and OAR) per year.5 The analyses were stratified as follows:
(1) women: OAR vs EVAR, (2) men: OAR vs EVAR, (3)
EVAR: men vs women, and (4) OAR: men vs women.
Statistics. To control for life expectancies in the gen-
eral population, we used relative survival. Relative survival
was calculated using the life-table method14 by comparing
the observed survival after AAA repair (including and ex-
cluding operation-related mortality 90 days)15,16 with
the expected survival of the population17 adjusted for back-
ground death based on age, sex, and calendar year.
Because each treatment group was vastly different, to
control for baseline characteristics and assess solely the
effect of procedure or gender on survival, we used a
propensity-matching technique.18-22 To increase the pool
of data for matching, all 1995 to 2006 hospitalizations for
OAR and hospitalizations from 2000 through 2006 for
EVAR were included. To determine the propensity score, a
logistic regression model was developed where the depen-
dent variable was the type of procedure or gender. All baseline
Table I. Continued
OAR
Men Women
(n  186,726) (n  58,810)
74.56337 75.49
24.2 19.5
31.2 29.3
26.9 28.8
13.6 16.4
4.0 5.9
95.2 92.4
2.4 5.1
0.6 0.5
1.9 2.0
49.4 38.1
8.5 9.7
28.3 22.9
16.0 17.9
36.5 41.6
7.7 8.6
4.0 3.8
4.3 4.1
20.3 27.9
11.3 10.1
1.3 1.2
7.1 3.9
60.3 68.2
23.1 24.5EVAR vs OAR
P
Women Men
P P
.0001 .0001 .0001
.0001 .0001 .0001
.0001 .0001 .0001
.0001 .1557 .0074
.0001 .0001 .0001
.0001 .0001 .0001
.0001 .0001 0.4911
.0001 .0001 0.5267
.2929 .1627 0.9368
.0217 .8891 0.675
.0001 .0001 .0001
.0001 .0006 .0001
.0001 .0001 .0001
.0001 .0001 .0001
.0001 .5936 .0106
.0001 .0001 .0001
.0199 .0001 .0001
.0331 .0001 .0001
.0001 .9015 .0001
.0001 .0001 .0001
.1701 .3094 .0001
.0001 .0001 .0001
.0001 .0001 .0001
.0001 .0001 .0001confounders, including gender, race, comorbidities (as cate- Cable II. Five-year relative survival estimates for men
nd women after open (OAR) and endovascular (EVAR)
epair of abdominal aortic aneurysm (AAA)
ariable
Men Women
P% (95% CL) % (95% CL)
lective AAA
OAR 86 (86, 87) 77 (76, 77) .0001
EVAR 87 (87, 88) 80 (78, 81) .0001
xcluding 90-day mortality
OAR 93 (92, 93) 84 (84, 85) .0001
EVAR 91 (90, 91) 85 (83, 86) .0001
uptured AAA
OAR 34 (33, 35) 19 (18, 21) .0001
EVAR 43 (39, 48) 32 (25, 39) .0001
xcluding 90-day mortality
OAR 83 (82, 84) 72 (70, 74) .0001
EVAR 75 (67, 82) 65 (51, 78) .0001L, Confidence limit.
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July 20114 Egorova et algoric variables), age, year of surgery, hospital, and surgeon
volume (as continuous variables) were included in the model
as independent variables. The patients were matched by
greedy algorithm using the 8- to 1-digit matching scheme
without replacement.18 Paired t tests were used for continu-
ous variables and McNemar tests for categoric variables to
ensure that there were no significant differences in demo-
graphics and comorbid characteristics between matched
groups. The results of matching by propensity score are sum-
marized in Appendix Tables O2 and O3 (online only). Peri-
operative complications and 30-day mortality were compared
in matched groups using the McNemar test.
Survival curves were constructedwithCoxmodels. Frailty
models were used to control for matching (clustering). Haz-
ard ratio (HR) of long-term survival was estimated using the
SAS PROC PHREG procedure with the robust sandwich
estimate option.23,24 Propensity score and type of repair or
gender were included in this regression analysis. We used the
Martingale methods to check the proportional hazard as-
sumption. Readmission rates were compared with Poisson
regression analysis. Statistical significance was expressed as
both P values and 95% confidence intervals. P  .05 was
considered statistically significant. P values were reported
without adjusting for multiple comparisons. SAS 9.13 soft-
ware (SAS Institute Inc, Cary, NC) was used.
RESULTS
Elective AAA repair. There were 322,892 patients
with elective AAA repair from 1995 through 2006, and
245,536 underwent OAR (70.5%men, 29.5% women) and
77,356 underwent EVAR (82.4% men, 17.6% women).
Table III. Perioperative and long-term complications for
(OAR) repair of abdominal aortic aneurysm
Variable
W
EVAR, % O
(n  9080) (n
Disposition
Home/home care 82.7a
SNF/rehabilitation 12.3
Perioperative complications
Cardiac 4.45
Pulmonary 10.76
Renal failure w/dialysis 0.54
30-day mortality 3.19
Long-term adverse events/reinterventions
Readmission rate 0.75a
Ruptured AAA 0.29a
AAA revision 1.81a
Open 0.64a
Endovascular 1.09a
Arterial reinterventions 1.77a
Other reinterventionsb 2.28
SNF, Skilled nursing facility.
aRepresents a significantly higher rate.
bReinterventions for incision or laparotomy-related complications, including
or abdominal wall hernia repairs.Baseline characteristics of men and women are reported in sable I. The 30-day mortality rates for women were 6.43%
fter OAR and 2.96% after EVAR and for men were 4.64%
nd 1.63%, respectively. After adjusting for life expecta-
cy and calendar year, the 5-year relative survival for both
en and women was less than in the general population
nd was significantly lower for women thanmen after either
rocedure (Table II). The worst 5-year relative survival was
bserved in women undergoing OAR (84%).
Women: OAR vs EVAR. Women who underwent
VAR differed from those who underwent OAR: they were
lder, had a higher frequency of coronary artery disease
CAD) and diabetes, and a lower frequency of cardiac
rrhythmias and cerebrovascular disease (Table I). Adjust-
ent for these differences was accomplished by propensity
ig 1. Long-term survival of (A) women and (B) men treated
ith elective endovascular (EVAR) and open (OAR) repair of
ortic abdominal aneurysm (AAA). Cases were matched by pro-
ensity score. The hazard ratio (HR) is the quotient of the hazard
ates of the EVAR andOAR comparison groups and is expressed as
point estimate with a 95% confidence interval.
en and men after elective endovascular (EVAR) or open
Men
%
P
EVAR, % OAR, %
P80) (n  33,240) (n  33,240)
.0001 92.3a 77.6 .0001
.0001 5.1 15.5a .0001
a .0001 3.13 8.67a .0001
a .0001 7.01 26.14a .0001
a .0001 0.36 1.15a .0001
a .0001 1.84 4.80a .0001
.0001 0.63a 0.57 .0001
.0001 0.29a 0.10 .0001
.0001 1.94a 0.71 .0001
.0001 0.79a 0.52 .0001
.0001 1.11a 0.19 .0001
.0001 1.72a 0.63 .0001
a .0001 2.32 4.69a .0001
inal postoperative obstruction, postoperative adhesions and incisional, groinwom
omen
AR,
 90
64.8
26.2a
8.96
30.12
1.30
6.37
0.69
0.12
0.53
0.43
0.10
0.50
4.29core matching, which resulted in 9080 paired women who
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O2, online only).
The 30-day mortality in these matched groups was
6.37% after OAR and 3.19% after EVAR (P  .0001).
Higher rates of complications were observed in the OAR
group (Table III). EVAR recipients had a significant sur-
vival benefit that was sustained for the 6 years of observa-
tion (Fig 1,A). The relative risk of dying was 12% less in the
EVAR than in the OAR group (HR, 0.88; P  .0001).
However, EVAR recipients had higher rates of AAA and
arterial reinterventions, and OAR recipients had a higher
rate of laparotomy or incision-related reinterventions
(Table III).
Men: OAR vs EVAR. The balanced subgroups con-
sisted of 33,240 pairs (mean age, 75.5). Comorbidities
included CAD in 55%, congestive heart failure (CHF) in
16%, renal failure in 6%, and neurologic diseases in 4.6%
(Appendix Table O2, online only).
Perioperative mortality in these balanced groups was
1.84% after EVAR and 4.80% after OAR (P .0001; Table
III). Similar to women, rates of perioperative complications
were lower in the EVAR group.
Distinct from what was seen with women, the survival
advantage for EVAR was greatest during the first 2 postop-
erative years, but then the curves converged (Fig 1, B). The
relative risk of dying was about 4% lower for EVAR recipi-
ents (HR, 0.96; P .0049). Like women, men undergoing
EVAR had higher readmission, AAA, and arterial reinter-
vention rates, whereas OAR recipients had higher laparotomy-
related reinterventions (Table III).
Elective OAR: Men vs women. Demographics and
Table IV. Disposition, perioperative, and long-term comp
(OAR) of abdominal aortic aneurysm by gender
Variable
E
Men, %
(n  13,710) (n
Disposition
Home/home care 91.6a
SNF/rehabilitation 6.1
Perioperative complications
Cardiac 2.67
Pulmonary 6.23
Renal failure w/dialysis 0.39
30-day mortality 1.77
Long-term adverse events/reinterventionsa
Readmission rate 0.66
Ruptured AAA 0.33
AAA revision 2.04
Open 0.79
Endovascular 1.20
Arterial reinterventions 2.01
Other reinterventionsb 2.23
SNF, Skilled nursing facility.
aRepresents a significantly higher rate.
bReintervention for incisional or laparotomy-related complications, includ
groin, or abdominal wall hernia repairs.comorbidities of the balanced subgroups (59,279 pairs) are cvailable in Appendix Table O2 (online only). Mean age
as 75.4; comorbidities were CAD in 38%, CHF in 18%,
nd renal failure in 4%.
The 30-day mortality rate in these matched groups was
.43% for women and 4.98% for men (P .0001). Women
lso had higher rates of postoperative complications (Table
V). Men experienced superior survival throughout the
-year follow-up period (HR, 1.06; P  .0001; Fig 2, A).
he survival curves remained parallel, indicating that the
urvivals for the comparison groups as a whole were differ-
nt, conditional on the initial 2-year survival. Women ex-
erienced higher rates of readmission (0.66 vs 0.57 for
en, P  .0001), and slightly lower AAA revision rates
Table IV).
Elective EVAR: Men vs women. For this analysis we
ig 2. Long-term survival after elective (A) open (OAR) and (B)
ndovascular (EVAR) repair of men and women with aortic ab-
ominal aneurysms (AAAs). Cases were matched by propensity
core. The hazard ratio (HR) is the quotient of the hazard rates of
he two comparison groups (men and women) and is expressed as
point estimate with 95% confidence interval.
ions after elective endovascular (EVAR) or open repair
OAR
en, %
P
Men, % Women, %
P3,710) (n  59,279) (n  59,279)
7 .0001 80.0a 70.5 .0001
0a .0001 11.1 17.7a .0001
13a .0001 8.41 9.26a .0001
85a .0001 24.47 26.78a .0001
50 .205 0.96 1.27a .0001
96a .0001 4.98 6.43a .0001
77a .0001 0.57 0.66a .0001
28 .99 0.57 0.66 .1616
91 .1168 0.63a 0.48 .0049
63 .6306 0.52 0.43 .3077
21 .0444 0.11a 0.05 .0001
81 .3489 0.60 0.49 .1766
08 .1125 4.40a 3.96 .0325
testinal postoperative obstruction, postoperative adhesions and incisional,licat
VAR
Wom
 1
83.
12.
4.
9.
0.
2.
0.
0.
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42%, CHF in 16%, diabetes in 15%, and renal failure in 6%
(Appendix Table O2, online only).
The 30-day mortality rate was 2.96% for women and
1.77% for men (P  .0001), with women experiencing
higher rates of perioperative complications (Table IV).
Interestingly, although overall survival was superior for
men (HR, 1.07; P  .0136), the initial survival advantage
in men lessened over time, and the survival curves began to
converge after 2 years (Fig 2, B).
Ruptured AAA. Among the 48,865 patients with
rAAA repairs, 76.5% were men and 23.5% were women
(Table V), and only 2007 underwent EVAR. The ratio of
men to women by either approach was about 3:1 (OAR:
76.6% vs 23.4%; and EVAR: 74.6% vs 25.4%). Overall
30-day mortality 52.7% after OAR and 41.05% after EVAR
for women was and 44.06% after OAR and 33.07% after
EVAR for men. Regardless repair type, relative survival for
women was inferior to survival for men, with the worst
survival after EVAR (65%; Table II). Women were older,
with a mean age of 78 vs 76 years (P  .0001) and had
higher rates of valvular and pulmonary disease, CHF, renal
Table V. Baseline demographics and comorbidities for pa
of ruptured abdominal aortic aneurysm
Variable
Overall
Men Women
(n  37,371) (n  11,494)
Age, years 75.9 78.2
Age groups, %
65-69 20.9 13.1
70-74 26.9 21.0
75-79 25.5 25.8
80-84 16.9 23.0
85 9.8 17.1
Race, %
White 94.5 90.5
Black 3.1 6.9
Hispanic 0.6 0.5
Other race 1.9 2.1
Comorbidities, %
Coronary 28.6 24.7
Valvular 5.2 6.8
Arrhythmia 30.5 27.0
CHF 20.9 24.5
Pulmonary 35.0 37.3
Cerebrovascular 5.4 6.4
Neurologic 5.6 6.7
Renal failure 6.3 6.7
PAD 11.3 11.8
Diabetes 8.5 9.6
Liver disease 1.3 1.2
Cancer 4.8 3.1
Hypertension 44.8 53.4
Hyperlipidemia 9.9 11.2
Procedure, %
EVAR 4.0 4.4
Conversion
OAR 96.0 95.6
CHF, Congestive heart failure; PAD, peripheral arterial disease.failure, diabetes, hypertension, and hyperlipidemia. On the ather hand, men had higher rates of CAD, cardiac arrhyth-
ia, and cancer (Table V). Thus, we constructed four sets
f matched subgroups to compare survival after aortic
upture for men and women undergoing EVAR and OAR.
etails of patients’ baseline characteristics are reported in
ppendix Table O3 (online only).
Ruptured AAA women: OAR vs EVAR. Demo-
raphics and comorbidities of 495matched pairs of women
EVAR vs OAR) are available in Appendix Table O3 (on-
ine only). The mean age was 78 years, and 18% were aged
85. CADwas present in approximately 30%, CHF in 25%,
nd renal failure in 12%.
Perioperative mortality was significantly lower after
VAR (41.01%) compared withOAR (48.28%, P .0201)
n thesematched subgroups. Rates of postoperative cardiac,
ulmonary complications, and renal failure requiring dial-
sis were higher in the OAR recipients (Table VI).
Analysis of early data from 2000 to 2004 showed
quivalent survival for OAR and EVAR recipients even after
, 6, and 12 months of repair. However, when we included
ore recent years (2005 and 2006), we discovered a sur-
ival benefit of EVAR over OAR that persisted 6 months
s who had endovascular (EVAR) or open (OAR) repair
EVAR
P
Men Women
P(n  1497) (n  510)
.0001 77.5 78.8 .0003
.0001 15.8 13.5 .2245
.0001 23.2 17.1 .0037
.5083 24.1 23.5 .7891
.0001 22.4 26.7 .0484
.0001 14.6 19.2 .0127
.0001 92.3 87.5 .0009
.0001 5.6 10.6 .0001
.525 0.7 0.6 .7312
.189 1.3 1.4 .9507
.0001 37.6 30.6 .0043
.0001 8.6 8.0 .7196
.0001 33.7 33.3 .8903
.0001 22.8 26.5 .0905
.0001 39.4 38.0 .5831
.0001 6.9 7.6 .5957
.0001 6.2 6.9 .6037
.1409 11.8 11.8 .9962
.1342 13.7 15.7 .2656
.0001 10.8 11.8 .5576
.5139 1.2 1.6 .5276
.0001 7.4 6.5 .4755
.0001 59.3 64.1 .0555
.0001 19.8 22.5 .1797
.0416 100.0 100.0
6.9 7.3 .7743
.0416 0.0 0.0tientfter surgery (Fig 3, A). Overall survival rates were similar
6

5
d
c
L
1
r
p
a
b
g
w
T
w
a
h
.
s
d
JOURNAL OF VASCULAR SURGERY
Volume 54, Number 1 Egorova et al 7for EVAR and OAR recipients (HR, 0.94; P  .41).
Readmission, AAA revision, and arterial reinterventions
rates were significantly higher after EVAR (Table VI).
Ruptured AAAmen: OAR vs EVAR. We compared
OAR with EVAR outcomes in 1421 pairs of matched
men with rAAA. The mean age was 77; 14% were aged
85. Pulmonary disease was present in almost 40%,
CAD in about 38%, and renal failure in 11% (Appendix
Table O3, online only). Similar to women, men in these
matched groups had higher 30-day mortality after OAR
than after EVAR (43.70% vs 33.43% P  .0001) and a
higher rate of perioperative pulmonary complications
(Table VI). Distinct from what was observed with
women, overall survival was better for men with rAAA
after EVAR than after OAR (Fig 3, B). The overall
relative risk of dying was 15% higher in the OAR group
(HR, 0.85; P .0008), with lower readmission and AAA
reintervention rates (Table VI).
Ruptured AAAOAR:men vs women. We compared
the outcomes of men and women after OAR in two
matched subgroups, each with 10,911 individuals. They
were a mean age of 78 years, and CAD was present in 24%,
Table V. Continued
OAR
Men Women
(n  35,874) (n  10,984)
75.9 78.2
21.1 13.1
27.1 21.2
25.5 25.9
16.7 22.8
9.6 17.0
94.6 90.6
2.9 6.7
0.6 0.5
1.9 2.1
28.2 24.5
5.1 6.8
30.4 26.7
20.8 24.4
34.8 37.2
5.3 6.3
5.6 6.6
6.1 6.5
11.2 11.7
8.4 9.5
1.3 1.2
4.7 3.0
44.2 52.9
9.5 10.7
0.0 0.0
0.0 0.0
100.0 100.0CHF in 24%, pulmonary disease in 37%, and renal failure in r.5% (Appendix Table O3, online only). The mortality rate
30 days after OAR for rAAA in these balanced groups was
2.61% for women and 46.57% for men (Table VII). No
ifferences in perioperative cardiac, pulmonary, or renal
omplications between men and women were recorded.
ong-term survival was significantly higher for men (HR,
.17; P  .0001; Fig 4. A), whereas women had higher
eadmission and rAAA rates (Table VII).
Ruptured AAA EVAR: men vs women. We com-
ared the outcomes of matched pairs of men and women
fter EVAR with 499 individuals in each group. The distri-
ution of demographic characteristics was similar between
enders (Appendix Table O3, online only). Their mean age
as 79 years, and 46% of men and women were aged80.
he rate of underlying pulmonary disease was 38%, CAD
as about 32%, CHF was about 26%, and renal failure was
bout 10%.
The perioperative mortality rate was about 10%
igher for women (41.08%) than for men (30.66%; P 
0001), and women had substantially lower long-term
urvival (Fig 4, B), with a 33% higher relative risk of
ying (HR, 1.33; P  .0005) and higher readmission
EVAR vs OAR
P
Women Men
P P
.0001 .0564 .0001
.0001 .7839 .0001
.0001 .0239 .0008
.4551 .2331 .2162
.0001 .0412 .0001
.0001 .1914 .0001
.0001 .0167 .0002
.0001 .0008 .0001
.5623 .8319 .396
.1796 .2525 .1101
.0001 .0017 .0001
.0001 .2755 .0001
.0001 .001 .0073
.0001 .2942 .0608
.0001 .7169 .0003
.0001 .223 .0057
.0001 .8478 .3278
.1515 .0001 .0001
.215 .006 .0033
.0002 .0919 .0008
.4195 .4103 .8375
.0001 .0001 .0001
.0001 .0001 .0001
.0001 .0001 .0001
.0001 .0001
.0001 .0001















ates (Table VII).
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There are significant anatomic and biologic differences
between men and women that challenge the management
of aortic aneurysmal disease in women. The abdominal
aorta and iliac arteries in women are, on average, smaller;25-27
women tend to have a shorter infrarenal aortic neck,28,29
and their aneurysm more frequently involves the juxtarenal
and suprarenal aorta.30 Moreover, women with AAA are
older than men by at least 4 to 5 years7 and have more
cerebrovascular31 and iliac occlusive disease.7,12,13,28
The natural history of AAA disease in women is not as
well defined because of worse representation in clinical
trials. However, there is an indication that AAA might be
more dangerous in women. Data derived from United
Kingdom Small Aneurysm Trial (UKSAT) indicate that the
Table VI. Perioperative and long-term complications for
repair of ruptured abdominal aortic aneurysm (AAA)
Variable
W
EVAR, %
(n  495) (n
Disposition
Home/home care 27.7a
SNF/rehabilitation 25.9
Perioperative complications
Cardiac 16.16
Pulmonary 44.65
Renal failure w/dialysis 3.23
30-day mortality 41.01
Long-term complications/reinterventions
Readmission rate 1.02a
Ruptured AAA 1.72
AAA revision 2.19a
Open 0.94
Endovascular 1.25a
Arterial reinterventions 2.19a
Other reinterventionsb 2.97
SNF, Skilled nursing facility.
aRepresents a significantly higher rate.
bReintervention for incisional or laparotomy-related complications, includ
groin, or abdominal wall hernia repairs.
Fig 3. Long-term survival of (A) women and (B) men treated
with endovascular (EVAR) and open (OAR) repair of ruptured
aortic abdominal aneurysm. Cases were matched by propensity
score. The hazard ratio (HR) is the quotient of the hazard rate of
the EVAR and OAR comparison groups and is expressed as a point
estimate and 95% confidence interval.rupture rate is at least three times higher in women com- 4ared with men and that it occurs in smaller sized aneu-
ysms.32,33
Another concern is that women have higher rates of
ndiagnosed comorbid conditions that increase operative
isk, as has been documented for cardiovascular disease.34
ven when diagnosed, treatment tends to be underutilized:
omen with CAD are less likely to receive statins and
-blockers,35,36 and those with carotid stenosis are less likely
o receive antiplatelet treatment.37 Strong emerging evidence
rom clinical trials (Dutch Echographic Cardiac Risk Evalua-
ion Applying Stress Echo II and IV [DECREASE II and
V]) suggests that lack of medical optimization before
rocedures has a major adverse effect on perioperative
ardiovascular mortality and morbidity.38,39
The more challenging anatomy, higher chances of un-
iagnosed risk factors, and the higher likelihood of inade-
uate cardiovascular medical optimization, may partly ex-
lain why women with AAA have worse outcomes than
en. Indeed, the perioperative mortality rates in women
fter elective repair was reported as high as 10.6% in 1980
hrough 1990 in the Michigan registry, 3.8% higher than
en during the same period.10 More recent reports, which
eflect the introduction of EVAR and improved periopera-
ive management, continue to demonstrate this gender
isparity, with a mortality rate of 2.6% to 3.2% in men vs
.8% to 5.45% in women.9,40
With rAAA, the differences in mortality are more pro-
ounced.40,41 In the Michigan registry, the mortality rate
or women was 60.5%, 12% higher than for men. More
ecently, these rates have dropped in both groups, but a
ignificant gender disparity persists (52.9% in women vs
en and men after endovascular (EVAR) or open (OAR)
Men
, %
P
EVAR, % OAR, %
P95) (n  1421) (n  1421)
.0061 38.6a 26.7 .0001
.2053 22.9 25.0 .1883
1a .0326 17.80 19.92 .1499
5a .0017 43.07 53.48a .0001
7a .0078 3.66 5.00 .0739
8a .0201 33.43 43.70a .0001
9 .0002 0.92a 0.76 .0001
8 .1451 2.45 2.81 .8465
1 .0226 2.35a 0.79 .0001
1 .4089 0.82 0.72 .4488
.0081 1.53a 0.07 .0013
0 0.0134 1.79a 0.42 .0003
6 .3350 2.81 3.67 .6273
testinal postoperative obstruction, postoperative adhesions and incisional,wom
omen
OAR
 4
20.0
29.5
21.4
54.5
7.0
48.2
0.7
3.4
0.6
0.6
0.0
0.2
2.43% in men).9,40,41
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Volume 54, Number 1 Egorova et al 9The introduction of EVAR has reduced the rate of early
mortality with elective AAA repair.6,7,9,40,41 EVAR has
been frequently used for patients with multiple systemic
diseases and decreased life expectancy who would not tol-
erate themajor stress fromOAR. Indeed, the 5-year relative
survival for EVAR recipients compared with OAR recipi-
ents was uniformly worse. Even though women generally
have longer life expectancy than men, the observed 5-year
relative survival after AAA repair was lower for women than
men (Table II), which was consistent with previous obser-
vations.11 Women who received EVAR did the worst: 85%
after elective and only 65% after rAAA EVAR reached the
expected survival for their age group. This suggests that the
EVAR group consists of patients with higher rates of sys-
temic diseases, such as cancer, cardiac, and chronic pulmo-
nary diseases than in the general population, and these
Table VII. Perioperative and long-term complications for
repair of ruptured abdominal aortic aneurysm (AAA)
Variable
EV
Men, % W
(n  499) (n
Disposition
Home/home care 38.3a 2
SNF/rehabilitation 25.9 2
Perioperative complications
Cardiac 18.44 1
Pulmonary 39.68 4
Renal failure w/dialysis 3.41
30-day mortality 30.66 4
Long-term complications/reinterventions
Readmission rate 0.88
Ruptured AAA 2.70
AAA revision 1.67
Open 0.39
Endovascular 1.29
Arterial reinterventions 1.71
Other reinterventionsb 3.22
SNF, Skilled nursing facility.
aRepresents a significantly higher rate.
bReintervention for incisional or laparotomy-related complications, includ
groin, or abdominal wall hernia repairs.
Fig 4. Long-term survival after (A) open (OAR) and (B) endo-
vascular (EVAR) repair of ruptured aortic abdominal aneurysm in
men and women. Cases were matched by propensity score. The
hazard ratio (HR) is the quotient of the hazard rates of the two
comparison groups (men and women) and is expressed as a point
estimate and 95% confidence interval.factors are responsible for lower survival. cThis speculation obviously needs further investigation;
owever, it led us to construct matching pairs adjusted for
nown comorbidities to evaluate the effect of gender in
ong-term outcomes. We observed a survival benefit for
VAR that persisted for the entire 6 years of follow-up for
omen who underwent elective repair (Fig 1). This pattern
s distinct from what had been seen for EVAR use in a
ixed cohort of men and women in clinical trials. It is
ossible that long-term survival benefit after EVAR for
omen was not seen in clinical trials due to the under-
epresentation of women.
We also observed superior long-term survival with elec-
ive EVAR in men compared with women. However, the
urvival difference was greatest in the first 2 postoperative
ears and disappears afterward. This finding regarding the
ong-term equalization of survival curves after AAA repair is
eported here for the first time. It may reflect anatomic
ifferences between genders that favor women in the long-
erm. Women with AAA are less likely than men to have
ilated iliac arteries.13,28 Iliac artery dilation is often re-
ponsible for late reintervention and poor long-term out-
ome after primary intervention. The aortic wall in women
as different compliance than in men25,42 and probably
esponds differently to exclusion after insertion of a stent
raft. In fact, Ouriel et al12 have reported more rapid
hrinkage of the aortic sac in women undergoing EVAR.
For open procedures, both eAAA and rAAA, and ur-
ent EVAR, the survival benefit for men persisted. The
ecovery after OAR and rAAA repair appears to be more
omplicated for women. They experience higher rates of
ostoperative complications and are less likely to be dis-
en and men after endovascular (EVAR) or open (OAR)
OAR
%
P
Men, % Women, %
P9) (n  10,911) (n  10,911)
.0005 28.2a 19.6 .0001
1 17.6 20.1a .0001
.3576 19.78 19.79 .9864
.2059 49.95 48.93 .1319
1 5.13 4.83 .3041
a .0005 46.57 52.61a .0001
a .0052 0.66 0.80a .0001
.1721 2.34 2.43a .0104
.6938 0.81a 0.45 .0023
.3615 0.74a 0.41 .0051
.8779 0.07 0.02 .0688
.3808 0.47 0.32 .1989
.6752 4.70 4.06 .7936
testinal postoperative obstruction, postoperative adhesions and incisional,wom
AR
omen,
 49
7.9
5.9
6.23
3.69
3.41
1.08
1.04
1.76
2.08
0.80
1.28
2.13
3.04harged home. Such high rates were not seen for women
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July 201110 Egorova et alafter elective EVAR, reflecting that elective EVAR is less
invasive and less disruptive to body function. The favorable
anatomic factors for women may play a lesser role in the
case of elective open and urgent repair of rAAA. Women
with AAA are elderly andmore likely thanmen to live alone,
have sicker and older spouses incapable of caring for them,
or have lower income. For all these reasons, women after
OAR or rAAA repair are less likely to go home.9 Institu-
tionalization and poor functional status after intervention
may have an effect on long-term survival. Further analysis
of the causes of death and reasons for readmissions will be
very important to understand these findings.
Analysis of the long-term effect of gender on survival
after urgent repair alone uncovered additional findings of
interest. Initial data analysis from 2000 to 2004 showed no
benefit in survival of EVAR over OAR in women whose
aneurysm had ruptured. However, when we expanded the
analysis and included data from 2005 and 2006, we noticed
a 6-month advantage in survival in women undergoing
urgent EVAR. It is likely that this benefit will last longer in
the future as smaller-profile devices are used and operators
become more experienced in selecting the right devices for
the female anatomy in the face of the urgent nature of aortic
rupture.
One limitation of our study is that it is observational
and carries all the potential biases inherent to such study
designs. For instance, the subgroups of men and women
differed substantially (Tables I and IV). We adjusted our
comparisons for these differences by comparing propensity
score-matched cohorts; however, there may still be some
bias due to confounders that were not recognized. In
addition, men and women were matched according to age
and comorbidities and therefore some “healthier” men
were excluded from comparisons. Thus, the men in the
matched group may no longer be representative of all men
undergoing aortic procedures. Nevertheless, we think that
the matched comparisons are necessary to determine the
effect of gender alone, without the distorting effects of
other factors that could alter long-term survival.
Another limitation is that the data were originally col-
lected for administrative purposes and are subject to coding
errors. In addition, it is often difficult to distinguish
whether a second intervention is related to the initial aneu-
rysm repair. For instance, we assumed that all postoperative
arterial reconstructions were related to the initial AAA
repair, although they might have been performed for an
entirely different condition.
Finally, the ICD9-CM codes used for EVAR havemore
general use than those used for OAR. Therefore, readmis-
sion and reintervention rates were probably overestimated,
and it is quite possible our analysis carries a bias against
EVAR. Given that these limitations affect men and women
equally, the observed differences in reintervention and re-
admission rates should be accurate and the reported gender
effect should be real. A distinct benefit of using Medicare
data sets is that there is ample representation of women to
address issues of gender and that data sets reflect “realorld” medicine because they are derived from all types of
edical centers.
ONCLUSIONS
Our study is unique in identifying gender-related dif-
erences not only postoperatively but long-term after dif-
erent types of AAA repair. We observed sustained gender-
ssociated disparities in mortality favoring men after all
ypes of repairs in elective and urgent clinical settings.
owever, it is encouraging that EVAR has decreased long-
erm mortality in women after aortic aneurysm repair and
hat the women’s survival begins to equal men’s after 2
ears. Moreover, EVAR has begun to have a positive effect
n the urgent clinical setting of acute rupture with a pro-
onged benefit from this type of intervention. As experience
ith endovascular interventions grows and devices improve
o better fit the female anatomy, we believe that the historic
isparities in aortic outcomes between men and women
ay soon disappear.
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DrM. Schermerhorn (Boston, Mass): We’ve known that men
and women are different for a while now. There is a lower preva-
lence of aneurysms in women, they tend to occur later in life, and
they’ve got a higher rupture risk at any given diameter, and women
typically live longer than men. Your analysis has discovered some
important additional differences.
Why do you think there is this perioperative mortality differ-
ence between men and women? With many vascular surgical
procedures we’ve assumed it’s because of smaller arteries, but I’m
not sure that holds true for an aortic tube graft.As you showed, the EVAR-1, DREAM, and our prior Medi-
are analysis, showed the survival curves coming together after just
couple of years and we’ve heard many theories as to why this
appens. Your analysis forces us to re-think these theories and I’d
ike to get your thoughts on why the curves come together in the
en and why don’t they come together in the women.
Finally, I’d like to thank you for highlighting that we all need
o start thinking about the potential for gender disparities in other
rocedures as well.
Dr Egorova: As we all know, large data set analysis generates
ew hypotheses that can be verified in future clinical studies. The
urrent analysis showed that women compared to men had higher
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July 201112 Egorova et alperioperative mortality. The long-term survival was worse for
women after elective open repair and emergent repair of ruptured
AAA. The reasons for these gender disparities are not well under-
stood but certain hypothesis can be made.
Answer to question 1. Similar to any kind of vascular recon-
struction, immediate mortality after AAA was higher for women
than for men.We think that vascular anatomy (smaller arteries) and
devices not made to fit female anatomy play significant role. But we
agree that there are other not well understood factors responsible
for the higher mortality in women. One possible explanation is that
women tend to have unrecognized cardiovascular disease and
other, not well identified risk factors preoperatively and thus are
not as well optimized as their male counterparts before the surgery.
There is ample literature suggesting that cardiovascular disease in
women is more likely to be under-diagnosed, and when recog-
nized, women are less likely to be on aspirin, beta-blockers and
statins. Lack of aggressive treatment of cardiovascular disease may
contribute to higher mortality after procedures but, obviously,
further research is needed to give all the answers.
Answer to question 2. We also observed a difference in long-
term survival between men and women. It is well-known that
women live 6-7 years longer and should be able to catch up to men
in the long-term despite the initial perioperative disadvantage. And
they do after elective EVAR when the survival curves of men and
women coincide 2 years after surgery. The different pattern of
a
durvival was observed after elective open repair and repair of
uptured AAA. The survival curves remained parallel for the entire
ollow-up period with better survival for men. One speculation is
hat these procedures, as opposed to elective EVAR, cause signif-
cantly more stress to women. The recovery is more difficult and
rolonged, and women are less likely than men to return to their
reoperative level of function. In addition, women usually do not
ave the same level of socioeconomic support compared to men of
he same advanced age. In fact, studies have shown that after any
ascular procedure women are less likely than men to return home
nd are more likely to end up in an extended care facility. Level of
unction and long-term institutionalization influences significantly
ong-term survival. Again, we think that there are many other
arameters that cause such sustained discrepancy between genders
nd would like to explore more of these findings in the future
apers.
Answer to question 3. Finally, we observed small but sustained
ifference in survival for 6 years between women undergoing open
epair and women undergoing EVAR, favoring EVAR. Differences
n functionality after the two procedures probably play some role in
his finding. However, we are very curious to see if other authors
tilizing different databases will replicate our observations and we
re eager to further investigate this finding by analyzing causes of
eath and diagnoses at readmissions after the two procedures.
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(ICD-9-CM) codes for comorbidities and complications
Variable ICD-9-CM code
Comorbidities: Index hospitalization
Congestive heart failure 398.91, 402.01, 402.11, 402.91, 404.01, 404.03, 404.11, 404.91, 404.13,
404.93, 425.4, 425.5, 425.7, 425.8, 425.9, 428.0, 428.1, 428.20, 428.22,
428.30, 428.32, 428.40, 428.42, 428.9
Cardiac arrhythmia 426.0, 426.10, 426.11, 426.12, 426.13, 426.7, 426.9, 427.0, 427.1, 427.2,
427.3, 427.9, V45.0, V53.3
Valvular disease 093.2, 394, 395, 396, 397, 424, V42.2, V43.3
Coronary disease 412, 413, 414, 429.2
Diabetes 250
Hypertension 401, 402, 403, 404, 405
Pulmonary diseases 416, 417.9, 490, 491, 492, 493, 494, 495.0, 495.1, 495.2, 495.3, 495.4, 495.5,
495.6, 495.8, 495.9, 496, 500, 501, 502, 503, 504, 505, 506.0, 506.2, 506.4,
506.9, 508.1, 508.8, 508.9
Clinically significant lower extremity vascular
diseases
440.22, 440.23, 440.24, 440.3, 444.22, V43.4,
Renal atherosclerosis 440.1
Vascular intestine disease 557.1
Renal failure w dialysis V45.1, V56.0, V56.1, V56.2, V56.3, V56.8, 585.6, 39.95 (w/o 586)
Renal failure without dialysis 403.01, 403.11, 403.91, 404.02, 404.03, 404.12, 404.13, 404.92, 404.93,
585 (w/o 585.6), 588.0
Other renal diseases 582, 583.0, 583.1, 583.2, 583.4
Kidney transplant V420
Liver disease 070.22, 070.23, 070.32, 070.33, 070.44, 070.54, 070.9, 456.0, 456.1, 571,
572.1, 572.2, 572.3, 572.4, 572.8, 573.0, 573.1, 573.8, 573.9
Cerebrovascular diseases and paralysis 342, 344.1, 344.3, 344.4, 344.5, 344.9, 437.0, 438
Other neurological diseases 330, 331, 332, 333, 334.0, 334.1, 334.2, 334.4, 334.8, 335.0, 335.1, 335.2,
335.8, 335.9, 336.0, 336.2, 343, 344.0, 348.1, 348.3, 344.2, 344.6, 345,
437.3, 437.4, 437.5, 437.6, 437.7
Hyperlipidemia 272
Cancer 140, 141, 142, 143, 144,145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155,
156, 157, 158,159, 160, 161, 162, 163, 164, 165, 170, 171,172, 174, 175,
176, 179, 180, 181, 182, 183, 184, 185, 186, 187, 188, 189, 190, 191, 192,
193, 194, 195, 196, 197, 198, 199, 200, 201, 202, 203.0, 238.6
Rheumatoid arthritis 446, 701.0, 710.0, 710.1, 710.2, 710.3, 710.4, 710.8, 710.9, 711.2, 719.3, 714,
720, 725, 728.5, 728.89
Comorbidities: Preindex hospitalizations
History of heart failure 398.91, 402.01, 402.11, 402.91, 404.01, 404.03, 404.11, 404.91, 404.13,
404.93, 425.4, 425.5, 425.7, 425.8, 425.9, 428
Cardiac arrhythmia 426, 427.0, 427.1, 427.2, 427.3, 427.4, 427.5, 785.0, 996.01, 996.04, V45.0,
V53.3
Valvular disease 093.2, 394, 395, 396, 397, 424, V42.2, V43.3
Coronary disease 410, 412, 413, 414, 429.2
Pulmonary 415, 416, 417, 490, 491, 492, 493, 494, 495, 496, 500, 501, 502, 503, 504,
505, 506.0, 506.2, 506.4, 506.9, 508
Clinically significant lower extremity vascular
diseases
440.22, 440.23, 440.24, 440.3, 444.22, 996.7, V43.4
Renal atherosclerosis 440.1, 445.81
Vascular intestine disease 557.1, 557.9
Hypertension 401, 402, 403, 404, 405, 458.0, 458.1, 458.8, 458.9
Hyperlipidemia 272
Cerebrovascular diseases and paralysis 342, 344.1, 344.3, 344.4, 344.5, 344.9, 362.30, 362.31, 362.34, , 433, 434,
435, 436, 437.8, 437.9, 438, 784.3
Other neurological diseases 330, 331, 332, 333, 334.0, 334.1, 334.2, 334.3, 334.4, 334.8, 334.9, 336.0,
335.0, 335.1, 335.2, 335.8, 335.9, 336.0, 336.2, 340, 343, 344.0, 344.2,
344.6, 345, 348.1, 348.3, 430, 431, 432, 437.3, 437.4, 437.5, 437.6, 437.7,
780.3
Diabetes 250
Dialysis V45.1, V56.0, V56.1, V56.2, V56.3, V56.8, 585.6, 39.95
Renal failure without dialysis 403.01, 403.11, 403.91, 404.02, 404.03, 404.12, 404.13, 404.92, 404.93,
585 (w/o 585.6), 586, 588.0
Renal diseases 582, 583.0, 583.1, 583.2, 583.4, 583.6, 583.7
Liver disease 070.22, 070.23, 070.32, 070.33, 070.44, 070.54, 070.6, 070.9,456.0, 456.1,456.2, 571, 572.2, 572.3, 572.4, 572.8, 573
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Variable ICD-9-CM code
Cancer 140, 141, 142, 143, 144,145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155,
156, 157, 158,159, 160, 161, 162, 163, 164, 165, 170, 171,172, 174, 175,
176, 179, 180, 181, 182, 183, 184, 185, 186, 187, 188, 189, 190, 191, 192,
193, 194, 195, 196, 197, 198, 199, 200, 201, 202, 203.0, 238.6
Kidney transplant V42.0
Rheumatoid arthritis 446, 701.0, 710.0, 710.1, 710.2, 710.3, 710.4, 710.8, 710.9, 711.2, 719.3, 714,
720, 725, 728.5, 728.89, 729.30
Complications
Cardiac
Postoperative cardiac 997.1
Acute myocardial infarction 410.00, 410.01, 410.10, 410.11, 410.20, 410.21, 410.30, 410.31, 410.40,
410.41, 410.50, 410.51, 410.60, 410.61, 410.70, 410.71, 410.80, 410.81,
410.90, 410.91, 411.0, 411.1, 411.81, 411.89
Cardiac arrest 427.5
Acute CHF 428.21, 428.3, 428.31, 428.32, 428.41, 428.43
Acute dialysis 38.95
Pulmonary
Postoperative respiratory 997.3
Pulmonary collapse 518.0
Pulmonary edema 518.4
Postoperative pulmonary insufficiency 518.4
Respiratory failure 528.81, 518.82, 518.84
Pneumonia 481, 482.0, 482.1, 482.2, 482.30, 482.31, 482.32, 482.39, 482.81, 482.82,
482.83, 482.84, 482.89, 482.9, 485, 486
Pulmonary heart complications 415.0, 415.11, 415.12, 415.19
Tracheostomy 31.1, 31.29
Arterial reinterventions (thrombectomy,
embolectomy, catheter based and open
reconstructions cross-referenced with
diagnoses of AAA)
38.03, 38.04, 38.06, 38.08, 38.18, 38.38, 38.48, 38.86, 38.88, 39.24, 39.26,
39.49, 39.50, 39.59, 39.79, 39.90, 44.44, 88.42, 84.13, 84.14, 84.15, 84.16,
84.17, 88.42
Reinterventions for incision or laparotomy
related complications (incisional, groin or
abdominal wall hernia repairs, intestinal
postoperative obstruction, postoperative
53.0, 53.1, 53.2, 53.3, 53.5, 53.6, 54.1, 560.81, 568.0adhesion)
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endovascular (EVAR) elective repair of aortic abdominal aneurysm
Variable
Women Men
OAR EVAR
P
OAR EVAR
P(n  9080) (n  9080) (n  33,240) (n  33,240)
Age, years 76.7 76.8 .3841 75.4 75.5 .1271
Age groups, %
70-74 24.7 25.0 .655 27.0 27.5 .1743
75-79 29.4 29.4 .935 27.7 27.8 .7674
80-84 21.2 21.0 .7714 17.8 17.1 .0377
85 9.5 9.4 .7796 6.1 6.3 .2663
White race, % 90.4 90.8 .4142 94.8 94.9 .3998
Comorbidities, %
Hypertension 77.1 76.5 .3486 70.9 69.9 .0064
Atherosclerosis 20.4 20.8 .5691 16.9 16.8 .6105
PAD 26.1 27.3 .0721 20.2 20.4 .4699
Pulmonary 43.6 43.0 .4412 37.5 37.4 .7597
Coronary 41.4 41.4 .952 55.2 54.7 .1823
Valvular 10.6 10.6 .9809 9.4 9.3 .6693
Arrhythmia 22.0 22.1 .8994 28.2 27.9 .3764
CHF 16.3 16.4 .8568 15.6 15.6 .9915
Hyperlipidemia 40.1 38.8 .0824 40.2 38.3 .0001
Neurologic disorder 4.7 4.7 .8611 4.6 4.6 .9556
Renal failure 6.0 6.0 1 6.4 6.0 .027
Liver disease 1.1 1.2 .8897 1.2 1.1 .6343
Cancer 4.8 4.6 .5984 7.7 8.0 .1979
Diabetes 14.2 14.1 0.8806 15.6 15.1 .0836
Annual volume in OAR
Surgeon 7.29 7.01 .0028 7.93 7.66 .0001
Hospital 25.47 25.57 .7894 27.64 27.83 .3711
Annual volume in EVAR
Surgeon 8.14 9.28 .0001 6.79 7.97 .0001
Hospital 24.23 24.83 .0827 21.91 22.65 .0001CHF, Congestive heart failure; PAD, peripheral arterial disease.
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EVAR OAR
Men Women
P
Men Women
P(n  13,710) (n  13,710) (n  59,279) (n  59,279)
77.4 77.4 .8964 75.4 75.4 .0252
22.3 23.0 .129 29.4 29.4 .8937
27.4 28.2 .1705 28.8 28.8 1
23.7 22.4 .0093 16.4 16.4 .7751
12.3 12.5 .6887 5.9 5.8 .6276
90.9 90.9 .9603 92.7 92.5 .0472
78.1 78.2 .8571 68.5 68.2 .3835
21.3 21.5 .6542 19.7 19.9 .464
27.0 27.8 .1345 26.9 27.7 .0017
42.5 41.9 .3089 41.4 41.6 .5458
42.4 42.4 .9411 37.9 38.2 .3764
10.6 10.7 .8445 9.6 9.7 .5312
20.2 20.7 .323 22.7 22.9 .2803
15.8 16.0 .5531 17.7 17.9 .4552
40.5 41.3 .1727 24.0 24.4 .1004
4.9 5.0 .8895 3.7 3.8 .6022
5.9 6.1 .4893 4.1 4.1 .8378
1.3 1.1 .247 1.2 1.2 .9574
4.9 4.8 .6536 3.8 3.9 .6264
15.1 14.9 .6823 9.8 10.0 .1675
6.64 6.66 .8257 10.72 10.76 .5635
25.22 25.24 .951 34.22 34.51 .0914
14.48 14.42 .7576 1.91 1.95 .1699
32.81 32.80 .9777 7.00 7.11 .2345
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endovascular (EVAR) repair of ruptured aortic abdominal aneurysm (rAAA)
Variable
Women Men
OAR EVAR
P
OAR EVAR
P(n  495) (n  495) (n  1421) (n  1421)
Year of AAA repair 2004 2004 .0005 2004 2004 .0001
Age, years 78.3 78.7 .03845 77.3 77.4 .07916
Age groups, %
65-69 13.7 13.7 1 16.7 16.0 .6465
70-74 18.6 17.4 .6242 23.6 23.4 .9304
75-79 27.1 23.6 .2211 22.9 24.3 .3805
80-84 23.0 26.5 .2374 22.6 22.0 .715
85 17.6 18.8 .6242 14.2 14.1 .9578
Race, %
White 89.1 87.7 .4861 92.8 92.5 .8307
Black 7.9 10.5 .1585 5.2 5.3 .8685
Hispanic 1.0 0.4 .2568 0.7 0.8 .8273
Other race 2.0 1.4 .4669 1.3 1.3 1
Comorbidities, %
Coronary 33.5 30.3 .2807 38.0 36.7 .4761
Valvular 9.1 7.9 .4969 8.4 8.1 .7835
Arrhythmia 37.8 33.5 .1596 34.3 33.3 .5529
CHF 25.1 26.5 .6008 22.4 22.4 1
Pulmonary 39.8 38.0 .5467 37.9 39.1 .5116
Cerebrovascular 8.7 7.5 .4969 8.3 6.8 .1366
Neurologic 7.3 6.7 .7009 5.9 6.3 .6394
Renal failure 12.5 11.7 .6949 11.2 11.5 .8104
PAD 13.3 15.2 .4171 14.5 12.9 .2287
Diabetes 11.7 12.1 .8383 9.8 10.8 .374
Liver disease 2.0 1.6 .6171 1.5 1.3 .5164
Cancer 6.3 6.1 .8946 7.1 7.5 .7175
Hypertension 65.5 63.8 .601 60.9 58.8 .2186
Hyperlipidemia 25.3 21.8 .2013 18.9 19.4 .7267
Annual volume
rAAA hospital 5.5 5.1 .0917 5.29 5.12 .2266
rAAA surgeon 2.1 2.1 .9247 2.10 2.11 .8096
OAR surgeon 6.5 5.9 .1317 5.81 5.56 .2111
EVAR surgeon 9.7 10.2 .1875 8.73 9.34 .0129
OAR hospital 25.6 23.9 .2458 23.42 23.17 .7753
EVAR hospital 28.1 28.3 .9198 26.10 26.66 .5316CHF, Congestive heart failure; PAD, peripheral arterial disease.
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EVAR OAR
Men Women
P
Men Women
P(n  499) (n  499) (n  10,911) (n  10,911)
2004 2004 .07734 2000 2000 .04701
78.7 78.7 9749 78.0 78.1 .1532
11.8 13.6 .3843 12.8 13.2 .3241
18.8 17.2 .4576 21.5 21.4 .7437
23.6 23.4 .9414 25.9 26.0 .8705
28.5 26.7 .5082 22.7 22.7 .9171
17.2 19.0 .4317 17.1 16.7 .4073
87.6 87.8 .9126 91.4 91.0 .3039
11.0 10.4 .729 6.2 6.3 .5221
0.6 0.6 1 0.5 0.5 .6222
0.8 1.2 .5271 2.0 2.1 .5055
33.7 31.1 .3494 24.3 24.5 .6632
7.8 8.0 .9104 6.6 6.7 .7419
35.1 33.3 .5394 26.9 26.8 .9003
25.3 26.3 .7055 23.4 24.3 .1254
38.3 38.1 .9503 37.5 37.2 .6071
7.8 7.8 1 6.3 6.3 .8878
5.4 7.0 .2935 5.9 6.6 .032
9.2 11.8 .1869 6.5 6.5 .7835
15.2 15.6 .8575 11.7 11.5 .6085
12.4 12.0 .846 9.4 9.4 .8888
1.4 1.6 .7963 1.1 1.2 .7513
6.6 6.6 1 3.1 3.0 .5977
63.3 63.7 .8886 52.6 52.6 .9882
24.6 22.0 .3285 10.5 10.6 .7238
5.098196 5.116233 .9403 4.6 4.6 .5611
2.188377 2.120241 .4668 2.0 2.0 .7032
6.066132 5.923848 .7506 7.1 7.2 .3662
11.83968 11.31864 .5843 1.4 1.4 .5202
24.19038 24.18637 .998 25.1 25.5 .3707
31.10421 29.88176 .5747 6.2 6.0 .3712
